Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2008-11-21Clinical Trial Update: Phase IIa Study to Investigate the Efficacy and Safety of SPP635 in Diabetic and Hypertensive Patients With Albuminuria [Phase 2]
A Phase IIa trial evaluating the efficacy and safety of SPP635 in hypertensive and type 2 diabetic patients with albuminuria has completed.
-
CLINICAL_TRIALS trial_result · 2008-11-20Clinical Trial Update: The Japan-Combined Treatment With Olmesartan and a Calcium Channel Blocker Versus Olmesartan and Diuretics Randomized Efficacy Study (J-CORE) [Phase 4]
Phase 4 randomized study in Japan comparing olmesartan plus a calcium channel blocker versus olmesartan plus a diuretic for hypertension has…
-
FDA approval · 2008-11-18FDA Approved: CARVEDILOL — Supplemental Application (Quallent Pharmaceuticals Health LLC)
FDA approved a supplemental application for carvedilol from Quallent Pharmaceuticals Health LLC, authorizing a generic carvedilol tablet pro…
-
FDA approval · 2008-11-04FDA Approved: METOPROLOL TARTRATE — Supplemental Application (Hospira, Inc.)
FDA approved a supplemental application for metoprolol tartrate by Hospira, Inc., indicating regulatory action on this generic product. The …
-
CLINICAL_TRIALS research · 2008-10-28Clinical Trial Update: Nutritional Supplements on Blood Pressure 2008 [Phase 1]
This document is an update on a Phase 1 clinical trial evaluating nutritional supplements for blood pressure management in hypertension.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2008-10-23Clinical Trial Update: Preventing Heart Disease in Underserved Patients [NA]
A completed clinical trial update from Temple University describing a study aimed at preventing heart disease in underserved patients with h…
-
FDA approval · 2008-10-22FDA Approved: LASIX — Supplemental Application (Validus Pharmaceuticals LLC)
The FDA approved a supplemental application for LASIX (furosemide) from Validus Pharmaceuticals LLC.
-
FDA approval · 2008-10-21FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for amlodipine besylate from Aurobindo Pharma Limited (ANDA 078021). This action approves change…
-
FDA approval · 2008-10-21FDA Approved: METOPROLOL TARTRATE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for Metoprolol Tartrate from Mylan Pharmaceuticals Inc., authorizing a generic version to be mar…
-
FDA approval · 2008-10-21FDA Approved: METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for Metoprolol tartrate and hydrochlorothiazide by Mylan Pharmaceuticals Inc., updating labeling for…
-
CLINICAL_TRIALS research · 2008-10-21Clinical Trial Update: Effect of Lacidipine and Losartan on 24 Hour Systolic Blood Pressure Variability in Elderly Hypertensive Patients [Phase 4]
This Phase 4 clinical trial assesses whether lacidipine and losartan influence 24-hour systolic blood pressure variability in elderly patien…
-
CLINICAL_TRIALS research · 2008-10-20Clinical Trial Update: Physical Therapy for Hypertensive Elderly [Phase 4]
This document notes completion of a Phase 4 clinical trial studying the effects of physical therapy on elderly individuals with hypertension…
-
CLINICAL_TRIALS trial_result · 2008-10-17Clinical Trial Update: Nebivolol Versus Carvedilol in Patients With Heart Failure
This clinical trial comparing nebivolol to carvedilol in patients with chronic heart failure (and hypertension) has been terminated.
-
CLINICAL_TRIALS trial_result · 2008-10-16Clinical Trial Update: Double-Blind Randomized Cross-Over Trial Comparing Metabolic Effects of Candesartan, Hydrochlorothiazide and Placebo [Phase 2]
This is a Phase 2, double-blind, cross-over clinical trial update evaluating the metabolic effects of candesartan, hydrochlorothiazide, and …
-
CLINICAL_TRIALS trial_result · 2008-10-15Clinical Trial Update: Exercise Intervention in Female School Children: Effect on Blood Pressure, Body Mass Index (BMI), and Maths Scores [Phase 2]
Phase 2 clinical trial update on a school-based exercise program for female school children with hypertension, assessing effects on blood pr…
-
CLINICAL_TRIALS trial_result · 2008-10-15Clinical Trial Update: Vascular Improvement With Olmesartan Medoxomil Study [Phase 4]
Phase 4 trial updating vascular outcomes with olmesartan medoxomil in hypertension has completed.
-
FDA approval · 2008-10-14FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
FDA approved a supplemental application for amlodipine besylate filed by Zydus Pharmaceuticals USA Inc., under the ANDA process.
-
FDA approval · 2008-10-08FDA Approved: BYSTOLIC — Supplemental Application (Allergan, Inc.)
The FDA approved Allergan's supplemental application for BYSTOLIC (nebivolol hydrochloride).
-
CLINICAL_TRIALS research · 2008-10-01Clinical Trial Update: Cardiovascular Phenotype Study in Patients With Obstructive Sleep Apnea Syndrome [EARLY_Phase 1]
An early-phase 1 clinical trial update for a cardiovascular phenotype study in patients with obstructive sleep apnea syndrome and hypertensi…
-
CLINICAL_TRIALS trial_result · 2008-10-01Clinical Trial Update: A Cohort Study of Morning Home Blood Pressure Measurement in Type 2 Diabetic Patients
A completed cohort study assessing morning home blood pressure measurements in patients with hypertension and type 2 diabetes.
-
FDA approval · 2008-09-30FDA Approved: CARVEDILOL — Supplemental Application (UNICHEM PHARMACEUTICALS (USA), INC.)
FDA approved a supplemental application for carvedilol from Unichem Pharmaceuticals (USA), Inc., expanding labeling for this product.
-
CLINICAL_TRIALS trial_result · 2008-09-30Clinical Trial Update: Does Statin Therapy Reduce Sympathoexcitation in Hypertension? [NA]
The clinical trial evaluating whether statin therapy reduces sympathoexcitation in hypertension has completed, according to the update.
-
FDA label_change · 2008-09-25FDA Approved: VASERETIC — Supplemental Application (Bausch Health US, LLC)
FDA approved a supplemental application for VASERETIC (enalapril maleate and hydrochlorothiazide) submitted by Bausch Health US, LLC, reflec…
-
CLINICAL_TRIALS research · 2008-09-25Clinical Trial Update: Development and Pilot-Testing of a Patient Self Management Approach for Hypertension Using Personal Electronic Health Records [NA]
This clinical trial update describes a pilot study evaluating a patient self-management approach for hypertension that uses personal electro…
-
CLINICAL_TRIALS trial_result · 2008-09-17Clinical Trial Update: The Short-Term Effect of a Technology Driven Weight Control (SMART) Program for Obese Adults [NA]
This clinical trial update reports the completion of a study evaluating the short-term effects of a technology-driven weight control program…